Cargando…

The prevalence of chronic kidney disease in South Africa - limitations of studies comparing prevalence with sub-Saharan Africa, Africa, and globally

BACKGROUND: Chronic kidney disease (CKD) is a globally significant non-communicable disorder. CKD prevalence varies between countries and within a country. We compared the prevalence rates of CKD in South Africa with sub-Saharan Africa, Africa, and globally. METHODS: We registered a systematic revie...

Descripción completa

Detalles Bibliográficos
Autores principales: Hariparshad, Sudesh, Bhimma, Rajendra, Nandlal, Louansha, Jembere, Edgar, Naicker, Saraladevi, Assounga, Alain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10029276/
https://www.ncbi.nlm.nih.gov/pubmed/36944928
http://dx.doi.org/10.1186/s12882-023-03109-1
_version_ 1784910106448625664
author Hariparshad, Sudesh
Bhimma, Rajendra
Nandlal, Louansha
Jembere, Edgar
Naicker, Saraladevi
Assounga, Alain
author_facet Hariparshad, Sudesh
Bhimma, Rajendra
Nandlal, Louansha
Jembere, Edgar
Naicker, Saraladevi
Assounga, Alain
author_sort Hariparshad, Sudesh
collection PubMed
description BACKGROUND: Chronic kidney disease (CKD) is a globally significant non-communicable disorder. CKD prevalence varies between countries and within a country. We compared the prevalence rates of CKD in South Africa with sub-Saharan Africa, Africa, and globally. METHODS: We registered a systematic review with the International Prospective Register of Systematic Reviews for prevalence studies reporting CKD stages III-V from 2013 to 2021. The analysis sought to explain any significant differences in prevalence rates. The R statistical package was used for data analysis. Comparisons included measures of effect size due to the large sample sizes analysed. We also compared sex differences in prevalence rates, common aetiologies, and type of study methodologies employed. RESULTS: Eight studies were analysed, with two from each region. The matched prevalence rates of CKD between the various regions and South Africa showed significant differences, except for one comparison between South Africa and an African study [p = 0.09 (95% CI − 0.04–0.01)]. Both sub-Saharan African studies had a higher prevalence than South Africa. One study in Africa had a higher prevalence, while the other had a lower prevalence, whilst one Global study had a higher prevalence, and the other had a lower prevalence compared to South Africa. The statistical differences analysed using the Cramer’s V test were substantially less than 0.1. Thus, differences in comparisons were largely due to differences in sample sizes rather than actual differences. CONCLUSION: Variable prevalence rates between regions included disparities in sample size, definitions of CKD, lack of chronicity testing and heterogeneous laboratory estimations of eGFR. Improved consistency and enhanced methods for diagnosing and comparing CKD prevalence are essential. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12882-023-03109-1.
format Online
Article
Text
id pubmed-10029276
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-100292762023-03-22 The prevalence of chronic kidney disease in South Africa - limitations of studies comparing prevalence with sub-Saharan Africa, Africa, and globally Hariparshad, Sudesh Bhimma, Rajendra Nandlal, Louansha Jembere, Edgar Naicker, Saraladevi Assounga, Alain BMC Nephrol Research BACKGROUND: Chronic kidney disease (CKD) is a globally significant non-communicable disorder. CKD prevalence varies between countries and within a country. We compared the prevalence rates of CKD in South Africa with sub-Saharan Africa, Africa, and globally. METHODS: We registered a systematic review with the International Prospective Register of Systematic Reviews for prevalence studies reporting CKD stages III-V from 2013 to 2021. The analysis sought to explain any significant differences in prevalence rates. The R statistical package was used for data analysis. Comparisons included measures of effect size due to the large sample sizes analysed. We also compared sex differences in prevalence rates, common aetiologies, and type of study methodologies employed. RESULTS: Eight studies were analysed, with two from each region. The matched prevalence rates of CKD between the various regions and South Africa showed significant differences, except for one comparison between South Africa and an African study [p = 0.09 (95% CI − 0.04–0.01)]. Both sub-Saharan African studies had a higher prevalence than South Africa. One study in Africa had a higher prevalence, while the other had a lower prevalence, whilst one Global study had a higher prevalence, and the other had a lower prevalence compared to South Africa. The statistical differences analysed using the Cramer’s V test were substantially less than 0.1. Thus, differences in comparisons were largely due to differences in sample sizes rather than actual differences. CONCLUSION: Variable prevalence rates between regions included disparities in sample size, definitions of CKD, lack of chronicity testing and heterogeneous laboratory estimations of eGFR. Improved consistency and enhanced methods for diagnosing and comparing CKD prevalence are essential. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12882-023-03109-1. BioMed Central 2023-03-21 /pmc/articles/PMC10029276/ /pubmed/36944928 http://dx.doi.org/10.1186/s12882-023-03109-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Hariparshad, Sudesh
Bhimma, Rajendra
Nandlal, Louansha
Jembere, Edgar
Naicker, Saraladevi
Assounga, Alain
The prevalence of chronic kidney disease in South Africa - limitations of studies comparing prevalence with sub-Saharan Africa, Africa, and globally
title The prevalence of chronic kidney disease in South Africa - limitations of studies comparing prevalence with sub-Saharan Africa, Africa, and globally
title_full The prevalence of chronic kidney disease in South Africa - limitations of studies comparing prevalence with sub-Saharan Africa, Africa, and globally
title_fullStr The prevalence of chronic kidney disease in South Africa - limitations of studies comparing prevalence with sub-Saharan Africa, Africa, and globally
title_full_unstemmed The prevalence of chronic kidney disease in South Africa - limitations of studies comparing prevalence with sub-Saharan Africa, Africa, and globally
title_short The prevalence of chronic kidney disease in South Africa - limitations of studies comparing prevalence with sub-Saharan Africa, Africa, and globally
title_sort prevalence of chronic kidney disease in south africa - limitations of studies comparing prevalence with sub-saharan africa, africa, and globally
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10029276/
https://www.ncbi.nlm.nih.gov/pubmed/36944928
http://dx.doi.org/10.1186/s12882-023-03109-1
work_keys_str_mv AT hariparshadsudesh theprevalenceofchronickidneydiseaseinsouthafricalimitationsofstudiescomparingprevalencewithsubsaharanafricaafricaandglobally
AT bhimmarajendra theprevalenceofchronickidneydiseaseinsouthafricalimitationsofstudiescomparingprevalencewithsubsaharanafricaafricaandglobally
AT nandlallouansha theprevalenceofchronickidneydiseaseinsouthafricalimitationsofstudiescomparingprevalencewithsubsaharanafricaafricaandglobally
AT jembereedgar theprevalenceofchronickidneydiseaseinsouthafricalimitationsofstudiescomparingprevalencewithsubsaharanafricaafricaandglobally
AT naickersaraladevi theprevalenceofchronickidneydiseaseinsouthafricalimitationsofstudiescomparingprevalencewithsubsaharanafricaafricaandglobally
AT assoungaalain theprevalenceofchronickidneydiseaseinsouthafricalimitationsofstudiescomparingprevalencewithsubsaharanafricaafricaandglobally
AT hariparshadsudesh prevalenceofchronickidneydiseaseinsouthafricalimitationsofstudiescomparingprevalencewithsubsaharanafricaafricaandglobally
AT bhimmarajendra prevalenceofchronickidneydiseaseinsouthafricalimitationsofstudiescomparingprevalencewithsubsaharanafricaafricaandglobally
AT nandlallouansha prevalenceofchronickidneydiseaseinsouthafricalimitationsofstudiescomparingprevalencewithsubsaharanafricaafricaandglobally
AT jembereedgar prevalenceofchronickidneydiseaseinsouthafricalimitationsofstudiescomparingprevalencewithsubsaharanafricaafricaandglobally
AT naickersaraladevi prevalenceofchronickidneydiseaseinsouthafricalimitationsofstudiescomparingprevalencewithsubsaharanafricaafricaandglobally
AT assoungaalain prevalenceofchronickidneydiseaseinsouthafricalimitationsofstudiescomparingprevalencewithsubsaharanafricaafricaandglobally